Medlab Clinical Limited carries a market capitalization of 15.07M, placing it among publicly traded companies globally.
| Market Cap | 15.07M |
| Enterprise Value | N/A |
Medlab Clinical Limited's stock has declined approximately -50.56179% over the past 52 weeks. The 50-day moving average sits at 6.60, while the 200-day moving average is 6.60.
| Beta (5Y) | N/A |
| 52-Week Price Change | -50.56179% |
| 50-Day Moving Average | 6.60 |
| 200-Day Moving Average | 6.60 |
| Average Volume (20 Days) | N/A |
Medlab Clinical Limited's most recent stock split took place on August 2, 2022 with a 150:1 split ratio.
| Last Split Date | 8/2/2022 |
| Split Ratio | 150:1 |